OneWorld Health, a drug development affiliate of PATH, develops safe, effective, and affordable new treatments for diseases disproportionately affecting people in the developing world.
OneWorld Health is the first non-profit drug research and development organization in the United States. We challenge the assumption that pharmaceutical research and development is too expensive to create the new medicines that the developing world desperately needs. By partnering and collaborating with industry and researchers, by securing donated intellectual property, and by utilizing the scientific and manufacturing capacity of the developing world, OneWorld Health can deliver affordable, effective, and appropriate new treatments where they are needed most. In 2011, OneWorld Health became an affiliate of PATH.
OWH is funded by the Bill & Melinda Gates Foundation, the UK government, Skoll Foundation, UBS Foundation, other foundations, and by individual donors.
